84. サルコイドーシス Sarcoidosis Clinical trials / Disease details

臨床試験数 : 149 / 薬物数 : 227 - (DrugBank : 81) / 標的遺伝子数 : 82 - 標的パスウェイ数 : 167

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03704610 (ClinicalTrials.gov)	March 28, 2019	10/10/2018	Efficacy of Remission-induction Regimen With Infliximabfor Severe Extrathoracic Sarcoidosis (EFIRTES ...	Efficacy of Remission-induction Regimen With Infliximabfor Severe Extrathoracic Sarcoidosis (EFIRTES ...	Extrathoracic Sarcoidosis	Drug: Infliximab;Drug: Placebo	Assistance Publique - Hôpitaux de Paris	NULL	Completed	18 Years	N/A	All	31	Phase 3	France
2	EUCTR2014-002224-26-NL (EUCTR)	07/05/2015	03/02/2015	Infliximab dosing based on blood concentrations in patients with sarcoidosis: smart dosing	A new dosing strategy of infliximabversus standard dosing in patients with severe sarcoidosis: optim ...	Sarcoidosis;Therapeutic area: Diseases [C] - Immune System Diseases [C20]	Trade Name: Remicade Product Name: Remicade	St. Antonius Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Netherlands
3	EUCTR2011-003630-13-NL (EUCTR)	22/11/2011	07/11/2011	Tracer for the imaging of disease activity in sarcoidosis in the lung	99mTc labelled anti-TNF-alpha for the imaging of disease activity in pulmonary sarcoidosis - TISS	Pulmonary sarcoidosis MedDRA version: 17.0;Level: PT;Classification code 10037430;Term: Pulmonary sa ...	Product Name: 99mTc-Infliximab Product Code: not applicable INN or Proposed INN: not applicable Other d ...	Sint Antonius Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Netherlands
4	NCT00073437 (ClinicalTrials.gov)	October 2003	20/11/2003	A Study of Infliximab in Patients With Sarcoidosis	A Multicenter, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Safety and Efficacy ...	Sarcoidosis	Drug: Infliximab	Centocor, Inc.	NULL	Completed	18 Years	N/A	Both	139	Phase 3	United States;Austria;Belgium;France;Germany;Netherlands;Sweden;Switzerland;United Kingdom;Italy

First Previous1Next Last